Weekly shot aims to shrink waistlines in major obesity trial
NCT ID NCT07467447
Summary
This study is testing a new weekly injection called LY3437943 (retatrutide) to see if it helps adults with obesity or overweight lose weight. About 300 participants will receive either the drug or a placebo (dummy injection) for 48 weeks, along with diet and exercise advice. The main goal is to measure how much body weight changes after 24 weeks and to check the treatment's safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, 518036, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.